CL
RNAM

CRCM LP’s Avidity Biosciences RNAM Stock Holding History

CRCM LP’s Portfolio RNAM Stock Details RNAM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-202,370
Closed -$14.6M – 10
2025
Q4 		$14.6M Buy
+202,370
New +$13.1M 4.93% 5

Other funds holding RNAM

CC
Corsicana & Co Corsicana, Texas $158M AUM

CRCM LP's RNAM Position: Q1 2026 in Review

CRCM LP sold out of Avidity Biosciences (RNAM) in Q1 2026, closing a stake of 202,370 shares — an estimated $14.6M sold.

CRCM LP first reported a position in RNAM in Q4 2025 and held it in 1 quarter. The position peaked at $14.6M in Q4 2025. 1 fund tracked by Wall St. Rank holds RNAM as of Q1 2026.

  • CRCM LP reported no remaining Avidity Biosciences position as of Q1 2026 after selling out during the quarter.
  • CRCM LP sold 202,370 Avidity Biosciences shares in Q1 2026, an estimated $14.6M.
  • CRCM LP first reported a position in Avidity Biosciences in Q4 2025 and held it in 1 quarter.
  • CRCM LP's Avidity Biosciences position peaked at $14.6M in Q4 2025.
  • 1 fund tracked by Wall St. Rank held Avidity Biosciences as of Q1 2026.

Based on CRCM LP's 13F filing for Q1 2026, filed 13 May 2026.